IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Teva to restructure operations, cut 5,000 jobs worldwide

October 11, 2013 | Natasha Alperowicz

Teva Pharmaceutical Industries (Petach Tikva, Israel), the world’s leading generic drugs maker, has announced plans to restructure its business, including a reduction of some 5,000 jobs, approximately 10% of its global workforce. The company says that these steps are part of its worldwide restructuring program, which includes divestment of noncore assets, improvement in manufacturing efficiency and reduction of excess capacity. The company expects to realize annualized cost savings of $2 billion by end 2017, compared with the previously guided $1.5 to $2.0...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa